FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Aspiro Pharma Ketorolac Tromethamine Injection Recall

Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, Fo…

Aspiro Pharma Limited

Risk level
Class II
Reported by FDA
Oct 29, 2025
Recall ID
D-0036-2026
Check your lot numberHow we source this data

Summary

Aspiro Pharma recalled Ketorolac Tromethamine Injection starting Oct 1, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0036-2026 on Oct 29, 2025. Reason: Presence of Particulate Matter: Particulate matter identified as glass. Status: Ongoing.

Why it was recalled

Presence of Particulate Matter: Particulate matter identified as glass

Product description

Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx only, Mfd. for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Mfd. by: ASPIRO PHARMA LIMITED, Telangana - 502281, INDIA., U.S. Contact Number: 1-866-495-1995, NDC 31722-307-25 (Carton), 31722-307-02 (Vial label).

Lot numbers, UPCs & expiration codes

Lot #: AS1240347A, Exp Date 09/2026; AS1240144A, Exp Date 05/2026; AS1240145A, AS1240146A, Exp Date 06/2026; AS1250295A, Exp Date 05/2027.

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0036-2026
Classification
Class II
Status
Ongoing
Recall initiated
Oct 1, 2025
FDA report date
Oct 29, 2025
Recall type
Voluntary: Firm initiated
Recalling firm
Aspiro Pharma Limited

Original FDA data

Every field from FDA enforcement report D-0036-2026, exactly as published.

Show all FDA fields
City
Siddipet (District)
Status
Ongoing
Country
India
Event ID
97711
Address
Survey No. 321, Biotech Park, Phase Iii
Address (line 2)
Karkapatla Village, Markook (Mandal)
Code information
Lot #: AS1240347A, Exp Date 09/2026; AS1240144A, Exp Date 05/2026; AS1240145A, AS1240146A, Exp Date 06/2026; AS1250295A, Exp Date 05/2027.
Report date
Oct 29, 2025
Product type
Drugs
Recall number
D-0036-2026
Classification
Class II
Recalling firm
Aspiro Pharma Limited
Reason for recall
Presence of Particulate Matter: Particulate matter identified as glass
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx only, Mfd. for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Mfd. by: ASPIRO PHARMA LIMITED, Telangana - 502281, INDIA., U.S. Contact Number: 1-866-495-1995, NDC 31722-307-25 (Carton), 31722-307-02 (Vial label).
Distribution pattern
Nationwide within the United States
Recall initiation date
Oct 1, 2025
Initial firm notification
Letter
Center classification date
Oct 21, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0036-2026, published Oct 29, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls